A meta-analysis of the vascular endothelial growth factor polymorphisms associated with the risk of pre-eclampsia.


Journal

Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797

Informations de publication

Date de publication:
29 05 2020
Historique:
received: 29 01 2019
revised: 08 02 2020
accepted: 19 03 2020
pubmed: 8 4 2020
medline: 30 3 2021
entrez: 8 4 2020
Statut: ppublish

Résumé

Backgroud: Pre-eclampsia (PE) is a common pregnancy-induced hypertension disease. Some case-control studies reported the association between vascular endothelial growth factor (VEGF) gene polymorphisms (rs3025039, rs2010963) and PE risk. However, these associations were inconsistent in several studies. Therefore, we conducted this meta-analysis to assess the role of VEGF gene polymorphisms in PE more precisely. Eligible studies were searched in PubMed, Embase, Web of Science and Chinese (Chinese National Knowledge Infrastructure (CNKI) and WanFang) databases. Statistical analyses were performed by Stata 12.0 software. Odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of the association. In addition, subgroup analyses, sensitive analyses and publication bias analyses were performed to further assess this meta-analysis. In total, 21 studies were included in the meta-analysis covering 2018 cases and 2632 controls. There were significant associations between VEGF polymorphisms (rs3025039, rs2010963) and PE risk in the overall populations. In the subgroup analyses, we found that rs3025039 polymorphism was associated with the increased risk of PE among Chinese. As for rs2010963 polymorphism, a significant association was observed in subgroup of Caucasian. The present study suggested that the two VEGF gene polymorphisms (rs3025039, rs2010963) are associated with increased risk of PE in different ethnic groups, which means that the targets may be useful genetic markers for early prediction of PE.

Identifiants

pubmed: 32255175
pii: 222591
doi: 10.1042/BSR20190209
pmc: PMC7240197
pii:
doi:

Substances chimiques

VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020 The Author(s).

Références

Am J Obstet Gynecol. 2007 Sep;197(3):271.e1-4
pubmed: 17826416
Mol Hum Reprod. 2009 Feb;15(2):115-20
pubmed: 19060000
BMC Pregnancy Childbirth. 2011 May 16;11:35
pubmed: 21575227
Int J Immunogenet. 2012 Jun;39(3):241-6
pubmed: 22257487
J Matern Fetal Neonatal Med. 2014 Nov;27(17):1754-60
pubmed: 25007988
Ultrasound Obstet Gynecol. 2019 Oct 31;:
pubmed: 31671479
Ultrasound Obstet Gynecol. 2020 Jan 24;:
pubmed: 31975510
Am J Med Genet A. 2004 Nov 1;130A(4):365-71
pubmed: 15384082
Arch Gynecol Obstet. 2015 May;291(5):1029-35
pubmed: 25322977
PLoS One. 2013 Nov 04;8(11):e78173
pubmed: 24223772
J Biochem. 2013 Jan;153(1):13-9
pubmed: 23172303
BMJ. 2011 Apr 07;342:d1875
pubmed: 21474517
Mol Hum Reprod. 2006 Apr;12(4):233-6
pubmed: 16517614
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Cold Spring Harb Perspect Med. 2015 Aug 20;5(10):
pubmed: 26292986
Hypertension. 2019 Oct;74(4):991-997
pubmed: 31446801
J Matern Fetal Neonatal Med. 2013 Mar;26(5):532-6
pubmed: 23102494
J Cell Physiol. 2017 Jun;232(6):1467-1477
pubmed: 27736039
Rev Bras Ginecol Obstet. 2011 Jul;33(7):158-63
pubmed: 22012426
Braz J Med Biol Res. 2018;51(8):e7311
pubmed: 29846433
Immunol Invest. 2013;42(8):749-62
pubmed: 23957473
Mol Hum Reprod. 2004 May;10(5):321-4
pubmed: 14997002
J Matern Fetal Neonatal Med. 2013 Feb;26(3):226-32
pubmed: 23039092
Semin Perinatol. 2009 Jun;33(3):130-7
pubmed: 19464502
Clin Exp Hypertens. 2016;38(7):578-585
pubmed: 27668980
J Hypertens. 2015 Nov;33(11):2294-302
pubmed: 26259119
Am J Epidemiol. 2011 Feb 15;173(4):363-75
pubmed: 21216841
Semin Nephrol. 2017 Jul;37(4):386-397
pubmed: 28711078
Twin Res Hum Genet. 2008 Feb;11(1):77-83
pubmed: 18251679
Lancet. 2005 Feb 26-Mar 4;365(9461):785-99
pubmed: 15733721
Clin Chim Acta. 2008 Mar;389(1-2):126-31
pubmed: 18167313
Biosci Rep. 2019 Feb 8;39(2):
pubmed: 30630878
J Obstet Gynaecol Res. 2015 Dec;41(12):1877-83
pubmed: 26486233

Auteurs

Weicheng Duan (W)

Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China.

Chenlu Xia (C)

Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China.

Kang Wang (K)

Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China.

Yijie Duan (Y)

Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China.

Ping Cheng (P)

Department of Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, P.R. China.

Bo Xiong (B)

Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH